Hinge Health (HNGE) announced that its board of directors has authorized a $250M share repurchase program. Daniel Perez, co-founder and CEO said, “Our strong free cash flow generation puts it in a position to invest in organic growth while concurrently evaluating targeted M&A and returning capital to shareholders. We expect to continue to invest in improving member outcomes and experiences, while increasing enrollment and reducing costs for our clients. We will also opportunistically repurchase shares to offset future dilution.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Hinge Health Announces $250 Million Share Buyback
- Buy Rating on Hinge Health, Inc.: Attractive Valuation and Strong Financial Position Amid Market Concerns
- Hinge Health management to meet with Piper Sandler
- Hinge Health’s Earnings Call: Strong Growth Amid Challenges
- Hinge Health price target raised to $71 from $70 at Piper Sandler